Analyst Ratings for Kairos Pharma (KAPA)

KAPA Rating Summary

  |   Expand Research on KAPA
Overall Rating: BUY   Rating Trend: =   Avg. $ Target: N/A
Rating Score: 10 / 10   Percentile Rank: 95%
Date Firm Analyst Type Rating
(Past)		 PT
(Past)		 Start $
(End $)		 % Chg. Details
4/3/2025 H.C. Wainwright
» Updated 9/22/2025		 Joseph Pantginis New Coverage Buy
(N/A)		 12.00
(N/A)		 0.92
(0.60)		 -34.78% Details
3/27/2025 Maxim Group Jason McCarthy New Coverage Buy
(N/A)		 4.00
(N/A)		 0.96
(0.60)		 -37.5% Details